Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Thu, 22-Jan 6:20 AM)
CRISPR Therapeutics Shows Up to 89% Lipid Reduction in Phase 1 Data—Gene Editing in Cardiovascular Disease Advances
Market Chameleon (Thu, 20-Nov 8:25 AM)
CRISPR Therapeutics Reports Strong Pipeline Momentum and Robust Cash Position—Phase 1 CTX310 Data Published in NEJM
Market Chameleon (Mon, 10-Nov 8:12 AM)
